Pharmacology of moxonidine:: An I1-imidazoline receptor agonist

被引：36
|
作者：
Ernsberger, P [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Div Hypertens, Dept Nutr, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Med Hypertens, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pharmacol & Neurosci, Cleveland, OH 44106 USA
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2000年 / 35卷
关键词：
imidazoline receptor; moxonidine; radioligand binding; PC12 pheochromocytoma cells; rats;
D O I：
10.1097/00005344-200000004-00005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The I-1-imidazoline receptor is a novel neurotransmitter receptor found mainly in the brainstem, adrenal medulla and kidney. The actions of moxonidine are described at the level of individual biomolecules, cells, tissues, organs and finally with integrative functions. The receptor functions at the cellular level works through arachidonic acid and phospholipid signaling cascades in neuronal cells with the net result of inhibiting sympathetic premotor neurons.
引用
收藏
页码：S27 / S41
页数：15
相关论文
共 50 条
  • [21] Role of I1-imidazoline receptors and α2-adrenoceptors in hemodynamic effects of moxonidine administration into the rostroventrolateral medulla
    Khokhlova, ON
    Murashev, AN
    Medvedev, OS
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 131 (04) : 336 - 339
  • [22] Effect of I1 imidazoline receptor agonist, moxonidine, in nitric oxide-deficient hypertension in pregnant rats
    Gairard, A
    Lopez-Miranda, V
    Pernot, F
    Beck, JF
    Coumaros, G
    Van Overloop, B
    La Roche, B
    Koehl, C
    Christen, MO
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 43 (05) : 731 - 736
  • [23] CENTRAL BLOOD-PRESSURE REGULATION - CURRENT FINDINGS ON EFFICACY OF MOXONIDINE, A SELECTIVE I(1)-IMIDAZOLINE RECEPTOR AGONIST
    SOLLNER, B
    PERFUSION, 1994, 7 (12): : 464 - 465
  • [24] Role of I1-Imidazoline Receptors and α2-Adrenoceptors in Hemodynamic Effects of Moxonidine Administration into the Rostroventrolateral Medulla
    O. N. Khokhlova
    A. N. Murashev
    O. S. Medvedev
    Bulletin of Experimental Biology and Medicine, 2001, 131 : 336 - 339
  • [25] Biphasic Dose-dependent Modulation of Cardiac Parasympathetic Activity by Moxonidine, an Imidazoline I1-receptor Agonist
    Turcani, Marian
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 52 (06) : 524 - 535
  • [26] PROTECTION IN GLUTAMATE-INDUCED NEUROTOXICITY BY IMIDAZOLINE RECEPTOR AGONIST MOXONIDINE
    Bakuridze, Kakhi
    Savli, Evren
    Gongadze, Niko
    Bas, Duygu Belkis
    Gepdiremen, Akcahan
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2009, 119 (10) : 1705 - 1717
  • [27] In diabetic gastroparesis moxonidine an imidazoline receptor agonist improves gastric emptying
    Wittmann, T
    Kiss, I
    Rosztóczy, A
    Izbéki, F
    Várkonyi, TT
    Róka, R
    Lonovics, J
    DIABETOLOGIA, 2002, 45 : A335 - A336
  • [28] Inhibition of the natriuretic action of the imidazoline receptor agonist moxonidine by indometacin in the rat
    Darkwa, FK
    Smyth, DD
    PHARMACOLOGY, 1995, 51 (06) : 347 - 355
  • [29] Imidazoline Antihypertensive Drugs: Selective I1-Imidazoline Receptors Activation
    Nikolic, K.
    Agbaba, D.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (04) : 209 - 216
  • [30] A NOVEL MECHANISM OF ACTION FOR HYPERTENSION CONTROL - MOXONIDINE AS A SELECTIVE I-1-IMIDAZOLINE AGONIST
    ERNSBERGER, P
    HAXHIU, MA
    GRAFF, LM
    COLLINS, LA
    DRESHAJ, I
    GROVE, DL
    GRAVES, ME
    SCHAFER, SG
    CHRISTEN, MO
    CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 : 27 - 41
12345